Role of endocardial septal ablation in the treatment of hypertrophic obstructive cardiomyopathy.
Septal reduction therapy is accepted as a first therapeutic option for symptomatic drug-resistant hypertrophic obstructive cardiomyopathy (HOCM). Although, surgical septal myectomy is the gold standard method, alcohol septal ablation is a well-studied alternative approach in the patients with suitable anatomy. Endocardial septal ablation (ESA) therapy was relatively new defined modality and outcomes of the procedure were not clearly elucidated yet. We aimed to review the clinical aspects of ESA procedure and provide some historical background.
Department of Cardiology, Kocaeli Derince Education and Research Hospital; Kocaeli-Turkey. aksutolga@gmail.com.
Tolga
T
Aksu
Department of Cardiology, Kocaeli Derince Education and Research Hospital; Kocaeli-Turkey.
Tümer Erdem
TE
Güler
Department of Cardiology, Bayrampaşa Kolan Hospital; İstanbul-Turkey.
Kıvanç
K
Yalın
Department of Cardiology, Bayrampaşa Kolan Hospital; İstanbul-Turkey.
Şükriye Ebru
ŞE
Gölcük
Department of Cardiology, Kocaeli Derince Education and Research Hospital; Kocaeli-Turkey.
Kazım Serhan
KS
Özcan
D002312:Cardiomyopathy, Hypertrophic / Q000628:therapy*; D017115:Catheter Ablation; D001026:Coronary Artery Bypass; D000431:Ethanol / Q000008:administration & dosage; D006346:Heart Septum / Q000187:drug effects*; D006801:Humans; D016896:Treatment Outcome
D000431:Ethanol